Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An update from Alpa Laboratories Limited ( (IN:ALPA) ) is now available.
Alpa Laboratories Limited has announced that it will close its trading window for dealings in the company’s shares from January 1, 2026 until 48 hours after the declaration of its unaudited financial results for the quarter ending December 31, 2025, in line with SEBI’s Prohibition of Insider Trading Regulations and its internal code of conduct. The move underscores the company’s adherence to regulatory norms on insider trading and aims to ensure that directors, employees and other insiders do not trade in the company’s securities while in possession of unpublished price-sensitive information, thereby reinforcing governance standards for investors and market participants.
More about Alpa Laboratories Limited
Alpa Laboratories Limited is an India-based pharmaceutical company, operating from Indore, Madhya Pradesh, and is listed on both the National Stock Exchange of India and the Bombay Stock Exchange under the scrip code ALPA/532878.
Average Trading Volume: 4,130
Technical Sentiment Signal: Hold
Current Market Cap: 1.63B INR
See more data about ALPA stock on TipRanks’ Stock Analysis page.

